CLINICAL_TRIALS
trial_result
· 2025-05-16
Clinical Trial Update: Adalimumab vs. Conventional Immunosuppression for Uveitis Trial [Phase 3]
Summary
Phase 3 trial comparing adalimumab to conventional immunosuppression for uveitis has completed. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: JHSPH Center for Clinical Trials | Conditions: Uveitis | Phase 3 | Status: COMPLETED | Results posted: 2025-05-16